Hesperidin

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameHesperidin
Drug Alias NameAurantiamarin橘皮苷橙皮甙橙皮苷橙皮素
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Irritable MoodVomiting +[22
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNetherlands +[7
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Active CompaniesMontreal Heart Institute
Active IndicationsCoronavirus Disease 2019 (COVID-19)Irritable MoodVomiting +[16
Inactive IndicationsObesityMetabolic SyndromeInsulin Resistance +[6

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG